{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T22:06:43Z","timestamp":1775686003353,"version":"3.50.1"},"reference-count":33,"publisher":"Public Library of Science (PLoS)","issue":"9","license":[{"start":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T00:00:00Z","timestamp":1632960000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Regional Malaria and other Communicable Disease Threats Trust Fund"},{"DOI":"10.13039\/100004425","name":"Asian Development Bank","doi-asserted-by":"crossref","award":["RETA 8763"],"award-info":[{"award-number":["RETA 8763"]}],"id":[{"id":"10.13039\/100004425","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["202935\/X\/16\/Z"],"award-info":[{"award-number":["202935\/X\/16\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosntds.org"],"crossmark-restriction":false},"short-container-title":["PLoS Negl Trop Dis"],"abstract":"<jats:p>Substandard and falsified (SF) antimalarials have devastating consequences including increased morbidity, mortality and economic losses. Portable medicine quality screening devices are increasingly available, but whether their use for the detection of SF antimalarials is cost-effective is not known. We evaluated the cost-effectiveness of introducing such devices in post-market surveillance in pharmacies in Laos, conservatively focusing on their outcome in detecting SF artemisinin-based combination therapies (ACTs). We simulated the deployment of six portable screening devices: two handheld near-infrared [MicroPHAZIR RX, NIR-S-G1], two handheld Raman [Progeny, TruScan RM]; one portable mid-infrared [4500a FTIR] spectrometers, and single-use disposable paper analytical devices [PADs]. We considered two scenarios with high and low levels of SF ACTs. Different sampling strategies in which medicine inspectors would test 1, 2, or 3 sample(s) of each brand of ACT were evaluated. Costs of inspection including device procurement, inspector time, reagents, reference testing, and replacement with genuine ACTs were estimated. Outcomes were measured as disability adjusted life years (DALYs) and incremental cost-effectiveness ratios were estimated for each device compared with a baseline of visual inspections alone. In the scenario with high levels of SF ACTs, all devices were cost-effective with a 1-sample strategy. In the scenario of low levels of SF ACTs, only four devices (MicroPHAZIR RX, 4500a FTIR, NIR-S-G1, and PADs) were cost-effective with a 1-sample strategy. In the multi-way comparative analysis, in both scenarios the NIR-S-G1 testing 2 samples was the most cost-effective option. Routine inspection of ACT quality using portable screening devices is likely to be cost-effective in the Laos context. This work should encourage policy-makers or regulators to further investigate investment in portable screening devices to detect SF medicines and reduce their associated undesired health and economic burdens.<\/jats:p>","DOI":"10.1371\/journal.pntd.0009539","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T17:32:13Z","timestamp":1633023133000},"page":"e0009539","update-policy":"https:\/\/doi.org\/10.1371\/journal.pntd.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Implementation of field detection devices for antimalarial quality screening in Lao PDR\u2014A cost-effectiveness analysis"],"prefix":"10.1371","volume":"15","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8501-6092","authenticated-orcid":true,"given":"Nantasit","family":"Luangasanatip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Panarasri","family":"Khonputsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9line","family":"Caillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Serena","family":"Vickers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Zambrzycki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Facundo M.","family":"Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul N.","family":"Newton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoel","family":"Lubell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2021,9,30]]},"reference":[{"key":"pntd.0009539.ref001","unstructured":"World Health Organizaion. A Study on the Public Health and Socioeconomic Impact of Substandard and Falsified Medical Products. Geneva, Switzerland: 2017."},{"key":"pntd.0009539.ref002","unstructured":"World Health Organization. WHO Global Surveillance and Monitoring System for Substandard and Falsified Medical Products. Geneva, Switzerland: 2017."},{"key":"pntd.0009539.ref003","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.jpba.2017.04.056","article-title":"An empirical review of antimalarial quality field surveys: the importance of characterising outcomes","volume":"147","author":"J Grech","year":"2017","journal-title":"J Pharm Biomed Anal"},{"key":"pntd.0009539.ref004","unstructured":"Definitions of Substandard and Falsified (SF) Medical Products. World Heal Organ n.d. https:\/\/www.who.int\/medicines\/regulation\/ssffc\/definitions\/en\/."},{"key":"pntd.0009539.ref005","unstructured":"Substandard, spurious, falsely labelled, falsified and counterfeit (SSFFC) medical products: Fact Sheet. World Health Organization. World Heal Organ 2016. https:\/\/www.who.int\/medicines\/regulation\/ssffc\/en\/."},{"key":"pntd.0009539.ref006","doi-asserted-by":"crossref","first-page":"f5064","DOI":"10.1136\/bmj.f5064","article-title":"What to do about unsafe medicines?","volume":"347","author":"G Buckley","year":"2013","journal-title":"BMJ"},{"key":"pntd.0009539.ref007","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1128\/CMR.00072-14","article-title":"Substandard\/counterfeit antimicrobial drugs","volume":"28","author":"T Kelesidis","year":"2015","journal-title":"Clin Microbiol Rev"},{"key":"pntd.0009539.ref008","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2471\/BLT.10.020410","article-title":"Growing threat from counterfeit medicines.","volume":"88","author":"World Health Organization","year":"2010","journal-title":"Bull World Heal Organ"},{"issue":"10258","key":"pntd.0009539.ref009","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019.","volume":"396","author":"GBD 2019 Diseases and Injuries Collaborators","year":"2020","journal-title":"Lancet"},{"key":"pntd.0009539.ref010","unstructured":"World Health Organization. World Malaria Report 2016. 2016. https:\/\/www.who.int\/malaria\/publications\/world-malaria-report-2016\/report\/en\/"},{"key":"pntd.0009539.ref011","volume-title":"Guidelines for the Treatment of Malaria","author":"WHO","edition":"3"},{"key":"pntd.0009539.ref012","first-page":"1","volume":"1","author":"S Ozawa","year":"2018","journal-title":"Prevalence and Estimated Economic Burden of Substandard and Falsified Medicines in Low- and Middle-Income Countries A Systematic Review and Meta-analysis"},{"key":"pntd.0009539.ref013","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/S1473-3099(12)70064-6","article-title":"Poor-quality antimalarial drugs in southeast Asia and sub-Saharan Africa","volume":"12","author":"GML Nayyar","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"pntd.0009539.ref014","doi-asserted-by":"crossref","first-page":"e197","DOI":"10.1371\/journal.pmed.0030197","article-title":"Manslaughter by fake artesunate in Asia\u2013will Africa be next?","author":"P Newton","year":"2006","journal-title":"PLoS Med"},{"key":"pntd.0009539.ref015","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1080\/14787210.2016.1187560","article-title":"A link between poor quality antimalarials and malaria drug resistance?","volume":"14","author":"P Newton","year":"2016","journal-title":"Expert Rev Anti-Infect Ther"},{"key":"pntd.0009539.ref016","first-page":"1","volume":"25","author":"S Sengaloundeth","year":"2009","journal-title":"A stratified random survey of the proportion of poor quality oral artesunate sold at medicine outlets in the Lao PDR\u2013implications for therapeutic failure and drug resistance"},{"key":"pntd.0009539.ref017","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4269\/ajtmh.15-0057","article-title":"A Repeat Random Survey of the Prevalence of Falsified and Substandard Antimalarials in the Lao PDR: A Change for the Better","volume":"92","author":"P Tabernero","year":"2015","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009539.ref018","doi-asserted-by":"crossref","first-page":"e000725","DOI":"10.1136\/bmjgh-2018-000725","article-title":"Field detection devices for screening the quality of medicines: a systematic review","volume":"3","author":"S Vickers","year":"2018","journal-title":"BMJ Glob Heal"},{"key":"pntd.0009539.ref019","article-title":"A multi-phase evaluation of portable screening devices to assess medicines quality for national Medicines Regulatory Authorities\u2013Introduction.","author":"C Caillet","journal-title":"PLoS NTD"},{"key":"pntd.0009539.ref020","article-title":"A comparative field evaluation of six medicine quality screening devices in Laos.","author":"C Caillet","journal-title":"PLoS NTD"},{"key":"pntd.0009539.ref021","article-title":"Laboratory evaluation of twelve portable devices for medicine quality screening.","author":"SC Zambrzycki","journal-title":"PLoS NTD"},{"key":"pntd.0009539.ref022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41182-019-0138-9","article-title":"Malaria prevalence, knowledge, perception, preventive and treatment behavior among military in Champasak and Attapeu provinces, Lao PDR: A mixed methods study","volume":"47","author":"P Vilay","year":"2019","journal-title":"Trop Med Health"},{"key":"pntd.0009539.ref023","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1186\/1475-2875-13-452","article-title":"Artemisinin resistance\u2013modelling the potential human and economic costs.","volume":"13","author":"Y Lubell","year":"2014","journal-title":"Malar J"},{"key":"pntd.0009539.ref024","unstructured":"Global Burden of Disease Collaborative Network. Globbal Burden of Disease Study 2019 (GBD 2019) Disability Weights, Seattle, United States of America: Institute for Health Matrics and Evaluation (IHME), 2020."},{"key":"pntd.0009539.ref025","unstructured":"Life Expectancy at Birth, Lao PDR (2018). The World Bank Data. https:\/\/data.worldbank.org\/indicator\/SP.DYN.LE00.IN?locations=LA"},{"key":"pntd.0009539.ref026","unstructured":"United Nations Office for the Coordination of Humanitarian Affairs 2016. https:\/\/www.unocha.org\/asia-and-pacific-roap\/lao."},{"key":"pntd.0009539.ref027","doi-asserted-by":"crossref","first-page":"e17439","DOI":"10.1371\/journal.pone.0017439","article-title":"Likely Health Outcomes for Untreated Acute Febrile Illness in the Tropics in Decision and Economic Models; A Delphi Survey.","volume":"6","author":"Y Lubell","year":"2011","journal-title":"PLoS One"},{"key":"pntd.0009539.ref028","volume-title":"Macroeconomics and health: investing in health for economic development.","author":"WHO Commission on Macroeconomic and Health","year":"2001"},{"key":"pntd.0009539.ref029","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.aca.2017.04.016","article-title":"Screening of unapproved drugs using portable Raman spectroscopy","volume":"973","author":"C Tondepu","year":"2017","journal-title":"Anal Chim Acta"},{"key":"pntd.0009539.ref030","doi-asserted-by":"crossref","first-page":"6453","DOI":"10.1021\/ac400989p","article-title":"Paper analytical devices for fast field screening of beta lactam antibiotics and antituberculosis pharmaceuticals","volume":"85","author":"AA Weaver","year":"2013","journal-title":"Anal Chem"},{"key":"pntd.0009539.ref031","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pone.0217910","article-title":"The economic impact of substandard and falsified antimalarial medications in Nigeria.","volume":"14","author":"SM Beargie","year":"2019","journal-title":"PLoS One"},{"key":"pntd.0009539.ref032","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.4269\/ajtmh.18-0334","article-title":"Modeling the economic impact of substandard and falsified antimalarials in the Democratic Republic of the Congo","volume":"100","author":"S Ozawa","year":"2019","journal-title":"Am J Trop Med Hyg"},{"key":"pntd.0009539.ref033","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12936-018-2628-3","article-title":"Development of an agent-based model to assess the impact of substandard and falsified anti-malarials: Uganda case study","volume":"18","author":"S Ozawa","year":"2019","journal-title":"Malar J"}],"container-title":["PLOS Neglected Tropical Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009539","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T17:33:06Z","timestamp":1633023186000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pntd.0009539"}},"subtitle":[],"editor":[{"given":"Vahid","family":"Yazdi-Feyzabadi","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2021,9,30]]},"references-count":33,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2021,9,30]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pntd.0009539","relation":{},"ISSN":["1935-2735"],"issn-type":[{"value":"1935-2735","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,30]]}}}